日本語English简体中文 繁體中文

002317 Guangdong Zhongsheng Pharmaceutical Co., Ltd.众生药业Shenzhen Stock Exchange

13 posts

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317) at a glance

Code
002317
Company
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Local name
众生药业
Market
Shenzhen Stock Exchange
Share price
CN¥25.30 +0.41 (+1.65%) Nov 9 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317) Stock Price History

Guangdong Zhongsheng Pharmaceutical Co., Ltd. closed at CN¥25.30 on Nov 9, 2026, −0.7% over 1 month, +21.1% over 1 year.

2026-10-09 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告 / 新薬・製品の承認 关于控股子公司一类创新药RAY1225注射液减重III期临床试验获得顶线…2026-10-10 新薬・製品の承認 关于全资子公司获得头孢克肟颗粒《药品注册证书》的公告2026-10-13 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告2026-10-23 上場・売買開始 关于全资子公司获得精氨酸布洛芬化学原料药上市申请批准通知书的公告2026-10-27 新薬・製品の承認 关于控股子公司收到一类创新药昂拉地韦片新增适应症的药物临床试验…2026-10-30 余資の運用 关于使用闲置自有资金进行委托理财的公告 / 四半期報告 2026年三季度报告 / 取締役会決議 第九届董事会第七次会议决议公告CN¥27.94CN¥22.02Oct 9Nov 9
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥27.94Oct 19
1-Month LowCN¥22.02Oct 30
1-Week Change+8.2%vs Nov 2
1-Month Change−0.7%vs Oct 9

If you had invested CN¥10,000 1 month ago, it would be worth CN¥9,925 today (−0.7%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −4.3%, while this stock moved −0.7%.

Last 10 Trading Days

DateCloseChange% Change
Nov 9 (Mon)CN¥25.30+0.41+1.65%
Nov 6 (Fri)CN¥24.89−0.25−0.99%
Nov 5 (Thu)CN¥25.14+0.70+2.86%
Nov 4 (Wed)CN¥24.44+2.22+9.99%
Nov 3 (Tue)CN¥22.22−1.17−5.00%
Nov 2 (Mon)CN¥23.39+1.37+6.22%
Oct 30 (Fri)CN¥22.02−1.61−6.81%
Oct 29 (Thu)CN¥23.63−0.13−0.55%
Oct 28 (Wed)CN¥23.76−0.14−0.59%
Oct 27 (Tue)CN¥23.90−2.65−9.98%
2026-09-22 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告 / 変更届 关于控股子公司完成工商变更登记的公告2026-09-30 新薬・製品の承認 关于获得富马酸依美斯汀滴眼液《药品注册证书》的公告2026-10-08 新薬・製品の承認 关于ZSP1601片纳入突破性治疗药物程序的公告2026-10-09 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告 / 新薬・製品の承認 关于控股子公司一类创新药RAY1225注射液减重III期临床试验获得顶线…2026-10-10 新薬・製品の承認 关于全资子公司获得头孢克肟颗粒《药品注册证书》的公告2026-10-13 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告2026-10-23 上場・売買開始 关于全资子公司获得精氨酸布洛芬化学原料药上市申请批准通知书的公告2026-10-27 新薬・製品の承認 关于控股子公司收到一类创新药昂拉地韦片新增适应症的药物临床试验…2026-10-30 余資の運用 关于使用闲置自有资金进行委托理财的公告 / 四半期報告 2026年三季度报告 / 取締役会決議 第九届董事会第七次会议决议公告CN¥29.00CN¥22.02Aug 10Nov 9
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥29.00Aug 13
3-Month LowCN¥22.02Oct 30
1-Month Change−0.7%vs Oct 9
3-Month Change−11.5%vs Aug 7

If you had invested CN¥10,000 3 months ago, it would be worth CN¥9,107 today (−8.9%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −8.0%, while this stock moved −8.9%.

Last 10 Trading Days

DateCloseChange% Change
Nov 9 (Mon)CN¥25.30+0.41+1.65%
Nov 6 (Fri)CN¥24.89−0.25−0.99%
Nov 5 (Thu)CN¥25.14+0.70+2.86%
Nov 4 (Wed)CN¥24.44+2.22+9.99%
Nov 3 (Tue)CN¥22.22−1.17−5.00%
Nov 2 (Mon)CN¥23.39+1.37+6.22%
Oct 30 (Fri)CN¥22.02−1.61−6.81%
Oct 29 (Thu)CN¥23.63−0.13−0.55%
Oct 28 (Wed)CN¥23.76−0.14−0.59%
Oct 27 (Tue)CN¥23.90−2.65−9.98%
2026-09-22 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告 / 変更届 关于控股子公司完成工商变更登记的公告2026-09-30 新薬・製品の承認 关于获得富马酸依美斯汀滴眼液《药品注册证书》的公告2026-10-08 新薬・製品の承認 关于ZSP1601片纳入突破性治疗药物程序的公告2026-10-09 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告 / 新薬・製品の承認 关于控股子公司一类创新药RAY1225注射液减重III期临床试验获得顶线…2026-10-10 新薬・製品の承認 关于全资子公司获得头孢克肟颗粒《药品注册证书》的公告2026-10-13 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告2026-10-23 上場・売買開始 关于全资子公司获得精氨酸布洛芬化学原料药上市申请批准通知书的公告2026-10-27 新薬・製品の承認 关于控股子公司收到一类创新药昂拉地韦片新增适应症的药物临床试验…2026-10-30 余資の運用 关于使用闲置自有资金进行委托理财的公告 / 四半期報告 2026年三季度报告 / 取締役会決議 第九届董事会第七次会议决议公告CN¥33.29CN¥20.82May 11Nov 9
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥33.29Jul 15
6-Month LowCN¥20.82Jun 17
3-Month Change−11.5%vs Aug 7
6-Month Change+12.2%vs May 8

If you had invested CN¥10,000 6 months ago, it would be worth CN¥11,376 today (+13.8%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −13.6%, while this stock moved +13.8%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥25.30+14.9%
Oct 2026CN¥22.02−8.4%
Sep 2026CN¥24.03−3.8%
Aug 2026CN¥24.97−4.8%
Jul 2026CN¥26.22+6.7%
Jun 2026CN¥24.57+4.4%
May 2026CN¥23.54+28.0%
2026-09-22 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告 / 変更届 关于控股子公司完成工商变更登记的公告2026-09-30 新薬・製品の承認 关于获得富马酸依美斯汀滴眼液《药品注册证书》的公告2026-10-08 新薬・製品の承認 关于ZSP1601片纳入突破性治疗药物程序的公告2026-10-09 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告 / 新薬・製品の承認 关于控股子公司一类创新药RAY1225注射液减重III期临床试验获得顶线…2026-10-10 新薬・製品の承認 关于全资子公司获得头孢克肟颗粒《药品注册证书》的公告2026-10-13 債務保証 关于公司为合并报表范围内子公司提供担保的进展公告2026-10-23 上場・売買開始 关于全资子公司获得精氨酸布洛芬化学原料药上市申请批准通知书的公告2026-10-27 新薬・製品の承認 关于控股子公司收到一类创新药昂拉地韦片新增适应症的药物临床试验…2026-10-30 余資の運用 关于使用闲置自有资金进行委托理财的公告 / 四半期報告 2026年三季度报告 / 取締役会決議 第九届董事会第七次会议决议公告CN¥33.29CN¥16.72Nov 10Nov 9
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥33.29Jul 15
52-Week LowCN¥16.72Mar 23
Year to Date+33.3%vs Dec 31
From 52-Week High−24.0%Jul 15

If you had invested CN¥10,000 1 year ago, it would be worth CN¥12,402 today (+24.0%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −9.2%, while this stock moved +24.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥25.30+14.9%
Oct 2026CN¥22.02−8.4%
Sep 2026CN¥24.03−3.8%
Aug 2026CN¥24.97−4.8%
Jul 2026CN¥26.22+6.7%
Jun 2026CN¥24.57+4.4%
May 2026CN¥23.54+28.0%
Apr 2026CN¥18.39−0.1%
Mar 2026CN¥18.40−3.1%
Feb 2026CN¥18.98−0.9%
Jan 2026CN¥19.15+0.9%
Dec 2025CN¥18.98−20.8%
Nov 2025CN¥23.95+24.0%
CN¥29.54CN¥10.56Nov 13, 2023Nov 9, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥29.54Jul 10, 2026
3-Year LowCN¥10.56Apr 7, 2025
Annualized Return+13.9%
Max Drawdown−46.5%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥14,752 today (+47.5%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +19.5%, while this stock moved +47.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥25.30+33.3%
2025CN¥18.98―
CN¥39.58CN¥9.05Nov 15, 2021Nov 9, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥39.58Nov 14, 2022
5-Year LowCN¥9.05Nov 15, 2021
Annualized Return+22.9%
Max Drawdown−73.3%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥27,956 today (+179.6%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +2.5%, while this stock moved +179.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥25.30+33.3%
2025CN¥18.98―
CN¥37.66CN¥4.95Jan 1, 2010Nov 9, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥37.66Nov 2022
All-Time LowCN¥4.95Jan 2012
Total Change+234.2%vs Jan 2010
Annualized Return+7.4%

If you had invested CN¥10,000 in Jan 2010, it would be worth CN¥33,421 today (+234.2%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +22.1%, while this stock moved +234.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥25.30+33.3%
2025CN¥18.98+56.2%
2024CN¥12.15−24.3%
2023CN¥16.05−40.5%
2022CN¥26.99+123.2%
2021CN¥12.09+9.7%
2020CN¥11.02−13.2%
2019CN¥12.70+52.1%
2018CN¥8.35−34.1%
2017CN¥12.68+2.7%
2016CN¥12.35−6.7%
2015CN¥13.24+37.9%
2014CN¥9.60−2.5%
2013CN¥9.85+27.5%
2012CN¥7.73+39.9%
2011CN¥5.52−26.2%
2010CN¥7.49―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2010). Please check the latest prices before trading.

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.13 Disclosure 2026/10/30 09:00
取締役会決議
第九届董事会第七次会议决议公告
Delete
No.12 Disclosure 2026/10/30 09:00
四半期報告
2026年三季度报告
Delete
No.11 Disclosure 2026/10/30 09:00
余資の運用
关于使用闲置自有资金进行委托理财的公告
Delete
No.10 Disclosure 2026/10/27 09:00
新薬・製品の承認
关于控股子公司收到一类创新药昂拉地韦片新增适应症的药物临床试验批准通知书的公告
Delete
No.9 Disclosure 2026/10/23 09:00
上場・売買開始
关于全资子公司获得精氨酸布洛芬化学原料药上市申请批准通知书的公告
Delete
No.8 Disclosure 2026/10/13 09:00
債務保証
关于公司为合并报表范围内子公司提供担保的进展公告
Delete
No.7 Disclosure 2026/10/10 09:00
新薬・製品の承認
关于全资子公司获得头孢克肟颗粒《药品注册证书》的公告
Delete
No.6 Disclosure 2026/10/09 09:00
新薬・製品の承認
关于控股子公司一类创新药RAY1225注射液减重III期临床试验获得顶线分析数据结果的公告
Delete
No.5 Disclosure 2026/10/09 09:00
債務保証
关于公司为合并报表范围内子公司提供担保的进展公告
Delete
No.4 Disclosure 2026/10/08 09:00
新薬・製品の承認
关于ZSP1601片纳入突破性治疗药物程序的公告
Delete
No.3 Disclosure 2026/09/30 09:00
新薬・製品の承認
关于获得富马酸依美斯汀滴眼液《药品注册证书》的公告
Delete
No.2 Disclosure 2026/09/22 09:00
変更届
关于控股子公司完成工商变更登记的公告
Delete
No.1 Disclosure 2026/09/22 09:00
債務保証
关于公司为合并报表范围内子公司提供担保的进展公告
Delete

Write on the Guangdong Zhongsheng Pharmaceutical Co., Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English